Free Trial
NASDAQ:IRD

Opus Genetics 3/31/2025 Earnings Report

Opus Genetics logo
$1.94 -0.02 (-0.77%)
As of 01:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Opus Genetics EPS Results

Actual EPS
-$1.27
Consensus EPS
-$0.34
Beat/Miss
Missed by -$0.93
One Year Ago EPS
N/A

Opus Genetics Revenue Results

Actual Revenue
$3.40 million
Expected Revenue
$11.10 million
Beat/Miss
Missed by -$7.70 million
YoY Revenue Growth
N/A

Opus Genetics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Opus Genetics' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Conference Call Resources

Opus Genetics Earnings Headlines

Analysts Set Opus Genetics, Inc. (NASDAQ:IRD) PT at $7.75
This dark force is about to change everything
An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and live. Porter Stansberry calls it The Final Displacement — a rare turning point that’s only happened four times in human history, each one redefining entire eras. His new documentary reveals why this shift could trigger both immense loss and unprecedented opportunity, and what you can do to prepare before it accelerates.tc pixel
Opus Genetics initiated with a Buy at Chardan
See More Opus Genetics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Opus Genetics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Opus Genetics and other key companies, straight to your email.

About Opus Genetics

Opus Genetics (NASDAQ:IRD) Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

View Opus Genetics Profile

More Earnings Resources from MarketBeat